Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
GPT Healthcare
Small Cap•1,924 Employees•IPO 2024
Current Price
₹124.42
-2.61 (-2.05%)Updated
Today's Range
122
₹124.42
126.57
52 Week Range
52W Low₹119.34
52W High₹185.00
₹124.42
Downside4.26%
Upside48.69%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹1,060.56 Cr
Market Cap
Total market value of companyP/E Ratio
24.38
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
4.76
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹5.29
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
9.37%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
23.60%
ROCE
Return on Capital Employed. >15% is goodNet Margin
11.08%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
-%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
-%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.14
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹30.21
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
65.60%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
4 points- •GPT Healthcare demonstrates robust profitability with an impressive Return on Equity (ROE) of 28.50% and Return on Capital Employed (ROCE) of 23.60%, indicating efficient capital utilization and strong operational performance.
- •The company maintains a healthy financial structure with a low debt-to-equity ratio of 0.60, suggesting prudent financial management and reduced reliance on external borrowings for its operations.
Weaknesses
4 points- •The company's latest quarterly net profit for June 2025 declined to 7.68 Cr from 12.89 Cr in March 2025, and is lower than 9.96 Cr in June 2024, indicating recent profit deceleration.
- •GPT Healthcare's stock price has seen a notable decline, currently trading at 151.00, significantly below its 52-week high of 192.00, reflecting potential investor apprehension or market corrections.
Opportunities
3 points- •Operating within the robust 'Healthcare' sector, GPT Healthcare is well-positioned to capitalize on the increasing demand for quality medical services and infrastructure expansion in the region.
- •The company's current PE ratio of 29.70 is considerably lower than many larger peers in the hospital industry, suggesting potential for a valuation re-rating as it scales up operations.
Threats
3 points- •GPT Healthcare faces intense competition from larger, well-established players in the 'Hospital' sector, such as Apollo Hospitals and Max Healthcare, which possess significantly greater market capitalization and resources.
- •The healthcare industry is subject to evolving regulatory frameworks and government policies, which could potentially impact the company's operational costs, pricing strategies, and overall profitability.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹135.80 | +₹11.38 | +9.15% |
| R3 | ₹131.23 | +₹6.81 | +5.47% |
| R2 | ₹128.90 | +₹4.48 | +3.60% |
| R1 | ₹126.66 | +₹2.24 | +1.80% |
| PIVOT | ₹124.33 | -0.09 | -0.07% |
| CURRENT | ₹124.42 | - | - |
| S1 | ₹112.95 | -₹11.47 | -9.22% |
| S2 | ₹117.52 | -₹6.90 | -5.55% |
| S3 | ₹119.76 | -₹4.66 | -3.75% |
| S4 | ₹122.09 | -₹2.33 | -1.87% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+357.7% vs avg
5.50L
(13 Mar 2026)Delivery %+23.6% vs avg
89.2%
(13 Mar 2026)Avg Volume (20D)20-day average
1.20L
(13 Feb - 13 Mar)Avg Delivery %Trend ↑
65.7%
(13 Feb - 13 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Apollo Hospitals Enterprise Ltd
1.09L ₹ Cr
Best Profit Growth
Apollo Hospitals Enterprise Ltd
41.80 %
Highest Dividend Yield
Indraprastha Medical Corporation Ltd
1.13 %
Peer Comparison
| Company Name |
|---|
 Apollo Hospitals Enterprise Ltd |
 Artemis Medicare Services Ltd |
 Indraprastha Medical Corporation Ltd |
 Lotus Eye Hospital & Institute Ltd |
 Max India Ltd |
 Shalby Ltd |
 Yatharth Hospital & Trauma Care Services Ltd |
About
GPT Healthcare Ltd
GPTHEALTH, operating under the ILS Hospitals brand, is a significant healthcare provider in India. Its core business centers around a network of multispecialty hospitals offering a comprehensive range of medical services. This expansive portfolio allows them to cater to a wide patient demographic and a broad spectrum of health needs.
The company's medical services are extensive, encompassing a wide array of specialties. These include internal medicine and diabetology for managing chronic conditions; nephrology, with a focus on advanced procedures like renal transplants; surgical expertise covering laparoscopic, general, and specialized areas such as bariatric and metabolic surgery; women's health services encompassing gynecology and obstetrics; and critical care services within their emergency departments.
Further specializations within GPTHEALTH's hospital network include gastroenterology for digestive health; orthopedics and joint replacement surgery; interventional cardiology for heart-related procedures; neurosciences for neurological conditions; pediatric and neonatal care; and urology. The incorporation of robotic procedures signifies a commitment to utilizing advanced technology for improved precision and minimally invasive surgical options.
Beyond its hospital network, GPTHEALTH extends its reach through ancillary services. These include the operation of clinics and pharmacies, providing convenient access to primary care and medication. The company also participates in academic endeavors and provides diagnostic services, enhancing its comprehensive approach to patient care. An unusual aspect of their operations involves the sale of power, suggesting a possible internal power generation capability supporting hospital operations or a separate revenue stream.
Established in 1989 and headquartered in Kolkata, India, GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd. Its long history and diversified services position it as a substantial player in the Indian healthcare landscape, indicating a commitment to long-term growth and development within the sector.
COMPANY FACTS - GPTHEALTH
Registered Address
GPT Centre, JC-25, Sector III, Salt Lake
Kolkata
WEST BENGAL
IN
Tel: 913340507000
Website:https://ilshospitals.com/
Company Details
Group: Health Care Equipment & Services
Sector: Health Care
Industry: Health Care Providers & Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 1,924
IPO Date: 29/02/2024
MANAGEMENT - GPTHEALTH
Dr. Om Tantia
Managing Director, Executive Director
Dr Pramod Sureka
Whole-Time Director
Mr. Saurabh Agarwal
Director
Mr. Bal Choudhury
Director
Himangsu Sinha
Director
Mr. Naval Totla
Nominee Director
Dr. Aruna Tantia
Non-Executive Non-Independent Director
Mr. Shree Tantia
Additional Non-Executive Non-Independent Director
Investor Questions Answered
GPT Healthcare Ltd (GPTHEALTH) Stock FAQs
Get answers to the most common questions about GPT Healthcare Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of GPT Healthcare Ltd (GPTHEALTH) is ₹124.42. Today, the stock has declined by ₹2.61 (2.05%), trading in a range of ₹122 to ₹126.57. The stock opened at ₹125.4 with a trading volume of 5,49,832 shares.
GPT Healthcare Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,060.56 crores, P/E ratio of 24.38, ROE of 9.37%, and ROCE of 23.60%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of GPT Healthcare Ltd (GPTHEALTH) is ₹185, while the 52-week low is ₹119.34. Currently trading at ₹124.42, the stock is 7.7% away from its 52-week low and 32.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy GPT Healthcare Ltd stock at ₹124.42 depends on multiple factors. The stock is currently trading with a P/E ratio of 24.38 and P/B ratio of N/A. Today's performance shows a loss of 2.05%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
GPT Healthcare Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹124.42, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
GPT Healthcare Ltd's key financial metrics include: P/E Ratio: 24.38, P/B Ratio: N/A, ROE: 9.37%, ROCE: 23.60%, Dividend Yield: 0.00%, EPS: ₹5.29, Book Value: ₹30.21, Debt-to-Equity: 0.14, and Current Ratio: N/A. The company's market cap stands at ₹1,060.56 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
GPT Healthcare Ltd stock opened at ₹125.4 and is currently trading at ₹124.42, showing a decline of ₹2.61 (2.05%). The intraday high is ₹126.57 and low is ₹122. The trading volume stands at 5,49,832 shares, indicating moderate market participation today.
GPT Healthcare Ltd has a Price-to-Earnings (P/E) ratio of 24.38, which means investors are willing to pay ₹24.38 for every ₹1 of earnings. With an EPS of ₹5.29, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
GPT Healthcare Ltd has a market capitalization of ₹1,060.56 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹124.42) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
GPT Healthcare Ltd has a book value of ₹30.21 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹124.42, which is 311.9% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
GPT Healthcare Ltd has a Return on Equity (ROE) of 9.37% and Return on Capital Employed (ROCE) of 23.60%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
GPT Healthcare Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
GPT Healthcare Ltd has a debt-to-equity ratio of 0.14, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
GPT Healthcare Ltd has an Earnings Per Share (EPS) of ₹5.29, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹124.42 and P/E ratio of 24.38, investors are paying 24.38 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
GPT Healthcare Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
GPT Healthcare Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze GPT Healthcare Ltd stock, consider: 1) Fundamental Analysis - Review P/E (24.38), ROE (9.37%), debt-to-equity (0.14), and growth rates. 2) Technical Analysis - Check 52-week range (₹119.34 - ₹185.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹124.42) with book value (₹30.21) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of GPT Healthcare Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹124.42 is 1144x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in GPT Healthcare Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹119.34 - ₹185.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.14 indicates leverage. 4) Liquidity Risk - Based on trading volume of 5,49,832 shares. 5) Valuation Risk - P/E of 24.38 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
GPT Healthcare Ltd operates in the industry with key metrics: P/E ratio of 24.38, ROE of 9.37%, market cap of ₹1,060.56 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.14), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for GPT Healthcare Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹124.42, with a 52-week range of ₹119.34 to ₹185.00. Based on fundamentals like P/E (24.38), ROE (9.37%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling GPT Healthcare Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹124.42. 2) Fundamental Deterioration - Declining ROE (currently 9.37%), increasing debt (D/E: 0.14), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for GPT Healthcare Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu